All research
Semaglutide 2025-01-20 ClinicalTrials

Empagliflozin and Semaglutide Efficacy and Safety Investigated for Overweight/Obese Type 1 Diabetes

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Abstract

Research aimed to evaluate empagliflozin or semaglutide efficacy and safety in overweight/obese patients with Type 1 Diabetes.


Source: clinicaltrials:NCT06762314 · Ingested 2026-08-04 · Digest: gemini-2.5-flash